首页|乳腺癌患者化疗呕吐发生情况及其影响因素分析

乳腺癌患者化疗呕吐发生情况及其影响因素分析

扫码查看
目的:研究分析乳腺癌患者化疗呕吐发生情况及影响因素.方法:回顾性调查2016年6月—2020 年 12 月莱西市人民医院收治的 500 例乳腺癌化疗患者的临床资料,将其化疗呕吐发生率进行统计.比较呕吐与未呕吐患者的年龄、焦虑自评量表(SAS)评分、营养状态、电解质情况、过敏史、晕动症史、胃肠道病史、基础疾病情况、肿瘤原发灶,病理淋巴结和转移分期(TNM分期)、分化程度、卡氏评分(KPS)、化疗前 24 h恶心呕吐情况、化疗药物方案、化疗药物数量及是否首次化疗等情况,logistic回归分析乳腺癌患者化疗呕吐发生的影响因素.结果:500 例化疗乳腺癌患者中呕吐者 236 例,发生率为47.20%.呕吐与未呕吐患者的年龄、营养状态、过敏史、基础疾病情况、TNM分期、分化程度及是否首次化疗情况比较,差异均无统计学意义(P>0.05);呕吐者的SAS评分>50 分、电解质失衡、晕动症史、胃肠道病史、KPS<80 分、化疗前 24 h恶心呕吐、含蒽环或铂类化疗方案及多药联合占比均显著高于未呕吐者,差异均有统计学意义(P<0.05).logistic回归分析显示,SAS评分>50 分、电解质失衡、晕动症史、胃肠道病史、化疗前 24 h恶心呕吐、含蒽环或铂类化疗方案及多药联合是乳腺癌患者化疗呕吐发生的危险因素(P<0.05).结论:乳腺癌患者化疗呕吐发生率较高,其影响因素包括SAS评分>50 分、电解质失衡、晕动症史、胃肠道病史、化疗前 24 h恶心呕吐、含蒽环或铂类化疗方案及多药联合.
Analysis on the Occurrence of Vomiting during Chemotherapy and Its Influencing Factors in Patients with Breast Cancer
Objective:To study and analyze the occurrence of vomiting during chemotherapy and its influencing factors in patients with breast cancer.Method:The clinical data of 500 patients with breast cancer admitted to Laixi People's Hospital from June 2016 to December 2020 were retrospectively investigated,and the incidence of vomiting during chemotherapy was calculated.The age,self-rating anxiety scale(SAS)score,nutritional state,electrolyte state,allergy history,motion sickness history,gastrointestinal disease history,basic disease condition,tumor primary lesion,pathological lymph node and metastasis classification(TNM stages),degree of differentiation,Karnofsky score(KPS),nausea and vomiting situation at 24 hours before chemotherapy,chemotherapy drug regimen,number of chemotherapy drugs and whether or not first chemotherapy of patients with vomiting and non-vomiting were compared,then the influence factors of vomiting during chemotherapy in patients with breast cancer were analyzed with logistic regression analysis.Result:236 cases of 500 patients with breast cancer treated with chemotherapy were with vomiting,the rate was 47.20%.The age,nutritional state,allergy history,basic disease condition,TNM stages,degree of differentiation,and whether or not first chemotherapy of patients with vomiting and non-vomiting were compared,the differences were not statistically significant(P>0.05);the proportion of the SAS score>50 points,electrolyte imbalance,motion sickness history,gastrointestinal disease history,KPS<80 points,nausea and vomiting situation at 24 hours before chemotherapy,chemotherapy regimens containing anthracycline or platinum and multidrug combination of patients with vomiting were significantly higher than those of patients with non-vomiting,the differences were statistically significant(P<0.05).The logistic regression analysis showed the SAS score>50 points,electrolyte imbalance,motion sickness history,gastrointestinal disease history,nausea and vomiting situation at 24 hours before chemotherapy,chemotherapy regimens containing anthracycline or platinum and multidrug combination were the risk factors of vomiting caused by chemotherapy of patients with breast cancer(P<0.05).Conclusion:The rate of vomiting caused by chemotherapy of patients with breast cancer is high,and the influencing factors include SAS score>50 points,electrolyte imbalance,motion sickness history,gastrointestinal disease history,nausea and vomiting situation at 24 hours before chemotherapy,chemotherapy regimens containing anthracycline or platinum and multidrug combination.

Breast cancerChemotherapyVomitingInfluencing factors

魏晓岑

展开 >

莱西市人民医院肿瘤科 山东 莱西 266600

乳腺癌 化疗 呕吐 影响因素

青岛市医药卫生科研计划

2021-WJZD327

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(6)
  • 20